Varicella
📧 Sign up to get email alerts when something new happens for Varicella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [Phase 2]
Phase 2 study assessing immunogenicity and safety of a combined Measles-Mumps-Rubella-Varicella vaccine (MeMuRu-OKA) compared with Priorix (…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety of the MeMuRu-OKA measles-mumps-rubella-varicella vaccine compared with Priorix given…
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of a combined measles, mumps, rubella, and varicella vaccine. The study has completed…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 3]
A Phase 3 trial assessed the immunogenicity and safety of a combined measles, mumps, rubella and varicella vaccine (MMRV) developed by Glaxo…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 4]
This Phase 4 trial update reports on the immunogenicity and safety of a combined measles, mumps, rubella, and varicella vaccine developed by…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [Phase 3]
This document reports long-term immunogenicity and safety results from a Phase 3 trial of the MMRV vaccine, evaluating durability of immune …
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. [Phase 3]
Phase 3 trial evaluating immunogenicity, reactogenicity and safety of a combined Measles, Mumps and Rubella vaccine produced by Bio-Manguinh…
-
FDA approval · 2016-04-08FDA Approved: ACYCLOVIR — Supplemental Application (Quinn Pharmaceuticals)
FDA approved a supplemental application for acyclovir submitted by Quinn Pharmaceuticals, indicating regulatory approval of a supplement for…
-
FDA approval · 2016-03-25FDA Approved: ACYCLOVIR — Original Application (Viona Pharmaceuticals Inc)
FDA approves the original application for acyclovir from Viona Pharmaceuticals Inc, making a generic version of acyclovir available.
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063) [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of VARIVAX New Seed Process in children with varicella has completed, with results posted…
-
FDA approval · 2016-02-29FDA Approved: ACYCLOVIR — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc. for an original application of acyclovir as a generic product, expanding generic options for acy…
-
FDA approval · 2015-10-26FDA Approved: VALACYCLOVIR — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Valacyclovir submitted by Quallent Pharmaceuticals Health LLC. The action confirms regulator…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) [Phase 3]
This update reports the completion of a Phase 3 study evaluating Merck's Measles, Mumps, Rubella, and Varicella vaccine (ProQuad) in healthy…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: MMR and Varicella Vaccine in Premature Infants
A completed clinical trial evaluating the MMR vaccine and the varicella vaccine in premature infants.
-
FDA approval · 2015-08-20FDA Approved: ACYCLOVIR — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for acyclovir from Amneal Pharmaceuticals LLC, supporting a generic formulation of acyclovir.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: ZOSTAVAX(R) Local Registration Trial (V211-019) [Phase 3]
Phase 3 trial update for ZOSTAVAX in Varicella virus infection (NCT00444860) with status COMPLETED.
-
CLINICAL_TRIALS research · 2015-05-04Clinical Trial Update: Comparison of Immunization Quality Improvement Dissemination Study [NA]
This is a completed clinical trial examining a immunization quality improvement dissemination study sponsored by Children's National Researc…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Evaluation Of Valaciclovir In Patients With Chickenpox [Phase 3]
A Phase 3 clinical trial evaluating valaciclovir for varicella (chickenpox) has completed.
-
FDA approval · 2015-04-08FDA Approved: VALACYCLOVIR — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved Quallent Pharmaceuticals Health LLC's original ANDA for Valacyclovir, providing a generic option for treating common herpes inf…
-
CLINICAL_TRIALS withdrawal · 2015-01-27Clinical Trial Update: A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062) [Phase 3]
A Phase 3 trial evaluating a new manufacturing process for VARIVAX to immunize against varicella has been withdrawn.
-
FDA approval · 2014-10-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Valacyclovir hydrochloride from Aurobindo Pharma Limited, granting approval of a generic product…
-
FDA label_change · 2014-09-29FDA Approved: ACYCLOVIR — Supplemental Application (ACTAVIS PHARMA, INC.)
FDA approved a supplemental application for Acyclovir (Actavis Pharma) to update the labeling.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine [Phase 4]
A Phase 4 trial evaluated immunogenicity and safety of two doses of a live attenuated varicella vaccine. The study has completed.
-
FDA approval · 2014-08-19FDA Approved: ACYCLOVIR — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original (ANDA) application for a generic acyclovir product from Zydus Pharmaceuticals (USA) Inc., enabling a generic versi…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of an alternative manufacturing process for MMRV vaccine (AMP) with comple…